Quality Improvement Grants to Support Development of Cardiac Amyloid Centers  
https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2021-02/GMG_2021-RD-L_QIAmyloidCenterUS.pdf?GA3OmXEQGV2qWnfoNJJA76XhnqaVHSMZ
Grant Application due date: April 8, 2021
Projects that will be considered for Pfizer support will focus on supporting the development of cardiac amyloid centers that provide leadership, best practices, support and/or training of HCPs within a multidisciplinary team environment in order to improve the quality of care for cardiac amyloidosis patients.
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Transthyretin Cardiac Amyloidosis Fellowship
url   https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2021-02/GMG_2021-RD-L_CardiacAmyloidosisFellowshipUS.pdf?5mqe2ImlQLOcpBib_98T92r4Xo1YmxiW=
Deadline June 15, 2021.
The intent of this program is to support institutions with fellowship programs for Cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of transthyretin cardiac amyloidosis.  Grant funding is available to support one fellow for up to a year at $80,000. The budget can include salary and support of the fellow benefits.

Independent Medical Education Grants to Close Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
url  https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2021-02/GMG_2021-RD-L_TTR-CMEducationUS.pdf?PjFtKFdJCSqIyLXPWkeZWdK_6qO2XbCD=
Deadline April 15, 2021
General Cardiologists, Heart Failure Nurse, Heart Failure Specialists, Neurologists, Echocardiographers, Nuclear Cardiologists, Primary Care Physicians

Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
url  https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2021-02/GMG_2021-RD-L_TTR-CMLocalEducationUS.pdf?Dp5D89WYrGnZYZDJG_ZvOaptYu2PkchY= 
Applications accepted on a rolling basis through September 30, 2021.
Educate health care providers to increase awareness and enable appropriate patient identification by closing knowledge gaps in disease epidemiology, pathophysiology, diagnosis, and emerging treatment paradigms.
Address barriers to appropriate diagnosis and strategies that reduce burdens for patients and providers along the pathway to appropriate diagnosis (see the url for complete description)